Suppr超能文献

新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。

The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.

作者信息

King A, Bethune L, Phillips I

机构信息

Microbiology Department, UMDS St. Thomas' Hospital, London, UK.

出版信息

J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.

Abstract

Tosufloxacin was highly active in vitro against most isolates of Enterobacteriaceae. It was slightly less active than ciprofloxacin for most species but more active than temafloxacin. It was the most active agent against Acinetobacter spp., Xanthomonas maltophilia and some Pseudomonas spp. but was slightly less active than ciprofloxacin against the fluorescent pseudomonads. Tosufloxacin was highly active against strains of Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae and Campylobacter coli/jejuni. It was the most active of the fluoroquinolones tested against staphylococci (MICs 0.016-0.25 mg/L), streptococci (MICs 0.06-1 mg/L) and enterococci (MICs 0.12-4 mg/L). Tosufloxacin was also the most active quinolone tested against anaerobic bacteria and, with the exception of a few isolates of Bacteroides spp. and some clostridia, all anaerobes had tosufloxacin MICs less than 1 mg/L.

摘要

妥舒沙星在体外对大多数肠杆菌科细菌分离株具有高度活性。对大多数菌种而言,其活性略低于环丙沙星,但高于替马沙星。它是对不动杆菌属、嗜麦芽窄食单胞菌和一些假单胞菌属最具活性的药物,但对荧光假单胞菌的活性略低于环丙沙星。妥舒沙星对流感嗜血杆菌、卡他莫拉菌、淋病奈瑟菌和大肠弯曲菌/空肠弯曲菌菌株具有高度活性。在测试的氟喹诺酮类药物中,它对葡萄球菌(MICs为0.016 - 0.25mg/L)、链球菌(MICs为0.06 - 1mg/L)和肠球菌(MICs为0.12 - 4mg/L)的活性最高。妥舒沙星也是测试的喹诺酮类药物中对厌氧菌活性最高的,除了少数拟杆菌属分离株和一些梭菌外,所有厌氧菌的妥舒沙星MICs均小于1mg/L。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验